Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Source:
    International Journal of Neuropsychopharmacology 2008
  • Additional Information
    • Author(s):
      O'Malley SS, Krishnan-Sarin S, McKee SA, Leeman RF, Cooney NL, Meandzija B, Wu R, Makuch RW
    • Review Group(s):
      Cochrane Drugs and Alcohol Group Trials in the Group's Specialized Register
    • Language:
    • Cochrane Study Design:
      RCT
    • Record Status:
      This record is updated this issue.
    • Source:
      This document should be cited as: O'Malley SS Krishnan-Sarin S McKee SA Leeman RF Cooney NL Meandzija B Wu R Makuch RW. Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation 2008 (The Cochrane Controlled Trials Register (CCTR/CENTRAL). Oxford: Update Software. Updated quarterly.
    • Accession Number:
      CN-00670848
  • Citations
    • ABNT:
      O’MALLEY SS et al. Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation. International Journal of Neuropsychopharmacology, [s. l.], p. 1–9, 2008. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cgh&AN=CN-00670848. Acesso em: 31 out. 2020.
    • AMA:
      O’Malley SS, Krishnan-Sarin S, McKee SA, et al. Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation. International Journal of Neuropsychopharmacology. January 2008:1-9. Accessed October 31, 2020. http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cgh&AN=CN-00670848
    • APA:
      O’Malley SS, Krishnan-Sarin S, McKee SA, Leeman RF, Cooney NL, Meandzija B, Wu R, & Makuch RW. (2008). Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation. International Journal of Neuropsychopharmacology, 1–9.
    • Chicago/Turabian: Author-Date:
      O’Malley SS, Krishnan-Sarin S, McKee SA, Leeman RF, Cooney NL, Meandzija B, Wu R, and Makuch RW. 2008. “Dose-Dependent Reduction of Hazardous Alcohol Use in a Placebo-Controlled Trial of Naltrexone for Smoking Cessation.” International Journal of Neuropsychopharmacology, January, 1–9. http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cgh&AN=CN-00670848.
    • Harvard:
      O’Malley SS et al. (2008) ‘Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation’, International Journal of Neuropsychopharmacology, pp. 1–9. Available at: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cgh&AN=CN-00670848 (Accessed: 31 October 2020).
    • Harvard: Australian:
      O’Malley SS, Krishnan-Sarin S, McKee SA, Leeman RF, Cooney NL, Meandzija B, Wu R & Makuch RW 2008, ‘Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation’, International Journal of Neuropsychopharmacology, pp. 1–9, viewed 31 October 2020, .
    • MLA:
      O’Malley SS, et al. “Dose-Dependent Reduction of Hazardous Alcohol Use in a Placebo-Controlled Trial of Naltrexone for Smoking Cessation.” International Journal of Neuropsychopharmacology, Jan. 2008, pp. 1–9. EBSCOhost, search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cgh&AN=CN-00670848.
    • Chicago/Turabian: Humanities:
      O’Malley SS, Krishnan-Sarin S, McKee SA, Leeman RF, Cooney NL, Meandzija B, Wu R, and Makuch RW. “Dose-Dependent Reduction of Hazardous Alcohol Use in a Placebo-Controlled Trial of Naltrexone for Smoking Cessation.” International Journal of Neuropsychopharmacology, January 1, 2008, 1–9. http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cgh&AN=CN-00670848.
    • Vancouver/ICMJE:
      O’Malley SS, Krishnan-Sarin S, McKee SA, Leeman RF, Cooney NL, Meandzija B, et al. Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation. International Journal of Neuropsychopharmacology [Internet]. 2008 Jan 1 [cited 2020 Oct 31];1–9. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cgh&AN=CN-00670848